Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine

Umbilical cord blood (UCB) and, more recently, umbilical cord tissue (UCT) have been stored cryopreserved in private and public cord blood and tissue banks worldwide, since the umbilical cord blood was used for the first time in a child with Fanconi anemia with his HLA-identical sibling, following s...

Full description

Saved in:
Bibliographic Details
Main Author: Ana Colette Mauricio (auth)
Format: Book Chapter
Published: IntechOpen 2017
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02339naaaa2200289uu 4500
001 doab_20_500_12854_61503
005 20210212
020 |a 62607 
020 |a 9789535128663 
020 |a 9789535128656 
024 7 |a 10.5772/62607  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Ana Colette Mauricio  |4 auth 
245 1 0 |a Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine 
260 |b IntechOpen  |c 2017 
300 |a 1 electronic resource (258 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Umbilical cord blood (UCB) and, more recently, umbilical cord tissue (UCT) have been stored cryopreserved in private and public cord blood and tissue banks worldwide, since the umbilical cord blood was used for the first time in a child with Fanconi anemia with his HLA-identical sibling, following strict guidelines that imply high-quality standards and total rastreability of these units. The hematopoietic stem cells (HSCs) are clinically used in hematopoietic treatments for blood disorders and hemato-oncological diseases. Also, the mesenchymal stem cells (MSCs) isolated from the UCT and UCB, nowadays, can be used as coadjuvants of hematopoietic transplants. In the near future, these stem cells will have a crucial role in regenerative medicine. For this reason, these cells have been tested in several clinical trials and compassive treatments in children and adults, concerning a wide range of pathologies and diseases, for instance, for the treatment of cerebral paralysis. Considering the worldwide availability of UCB and UCT units and the absence of ethical concerns will probably become the best sources for cell-based therapies for hematological and nonhematological pathologies. The UCB will also have a crucial role in neonatology-predictive analysis in the near future. 
540 |a All rights reserved  |4 http://oapen.org/content/about-rights 
546 |a English 
653 |a Medicine 
653 |a Stem Cell Research 
653 |a Health Sciences 
653 |a Cell Biology 
856 4 0 |a www.oapen.org  |u https://www.intechopen.com/books/umbilical-cord-blood-banking-for-clinical-application-and-regenerative-medicine  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/61503  |7 0  |z DOAB: description of the publication